Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raph L Hamers

Showing results (21-30 of 144) with videos related to

Pageof 15
Sort By:
The Lancet. Infectious Diseases|February 23, 2013
HIV-1 drug resistance in antiretroviral-naive patients in sub-Saharan AfricaRaph L Hamers, Kim Ce Sigaloff, Cissy Kityo, et al.
Antiviral Therapy|February 12, 2011
Multi-nucleoside reverse transcriptase inhibitor resistant HIV type-1 in a patient from Sierra Leone failing stavudine, lamivudine and nevirapineRaph L Hamers, Annemarie Mj Wensing, Nicole Kt Back, et al.
Antiviral Therapy|August 26, 2009
Dried fluid spots for HIV type-1 viral load and resistance genotyping: a systematic reviewRaph L Hamers, Pieter W Smit, Wendy Stevens, et al.
Antiviral Therapy|March 31, 2011
Interaction between antiretroviral drugs and acenocoumarolMarieke E B Welzen, Guido E L van den Berk, Raph L Hamers, et al.
Current Opinion in HIV and AIDS|November 13, 2012
Emerging HIV-1 drug resistance after roll-out of antiretroviral therapy in sub-Saharan AfricaRaph L Hamers, Kim C E Sigaloff, Cissy Kityo, et al.
BMJ (Clinical Research Ed.)|June 20, 2012
Global threat from drug resistant HIV in sub-Saharan AfricaRaph L Hamers, Cissy Kityo, Joep M A Lange, et al.
Wellcome Open Research|October 11, 2021
The WHO guideline on drugs to prevent COVID-19: small numbers- big conclusionsWilliam Hk Schilling, James J Callery, Arjun Chandna, et al.
Antiviral Therapy|September 6, 2008
The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan AfricaRaph L Hamers, Inge Derdelinckx, Michèle van Vugt, et al.
The Lancet. Infectious Diseases|March 24, 2019
Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimensSeth C Inzaule, Raph L Hamers, Meg Doherty, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 29, 2008
Diagnostic accuracy of 2 oral fluid-based tests for HIV surveillance in NamibiaRaph L Hamers, Ingrid H de Beer, Harold Kaura, et al.
Pageof 15

Showing results (21-30 of 144) with videos related to

Sort By:
Pageof 15
The Lancet. Infectious Diseases|February 23, 2013
HIV-1 drug resistance in antiretroviral-naive patients in sub-Saharan AfricaRaph L Hamers, Kim Ce Sigaloff, Cissy Kityo, et al.
Antiviral Therapy|February 12, 2011
Multi-nucleoside reverse transcriptase inhibitor resistant HIV type-1 in a patient from Sierra Leone failing stavudine, lamivudine and nevirapineRaph L Hamers, Annemarie Mj Wensing, Nicole Kt Back, et al.
Antiviral Therapy|August 26, 2009
Dried fluid spots for HIV type-1 viral load and resistance genotyping: a systematic reviewRaph L Hamers, Pieter W Smit, Wendy Stevens, et al.
Antiviral Therapy|March 31, 2011
Interaction between antiretroviral drugs and acenocoumarolMarieke E B Welzen, Guido E L van den Berk, Raph L Hamers, et al.
Current Opinion in HIV and AIDS|November 13, 2012
Emerging HIV-1 drug resistance after roll-out of antiretroviral therapy in sub-Saharan AfricaRaph L Hamers, Kim C E Sigaloff, Cissy Kityo, et al.
BMJ (Clinical Research Ed.)|June 20, 2012
Global threat from drug resistant HIV in sub-Saharan AfricaRaph L Hamers, Cissy Kityo, Joep M A Lange, et al.
Wellcome Open Research|October 11, 2021
The WHO guideline on drugs to prevent COVID-19: small numbers- big conclusionsWilliam Hk Schilling, James J Callery, Arjun Chandna, et al.
Antiviral Therapy|September 6, 2008
The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan AfricaRaph L Hamers, Inge Derdelinckx, Michèle van Vugt, et al.
The Lancet. Infectious Diseases|March 24, 2019
Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimensSeth C Inzaule, Raph L Hamers, Meg Doherty, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 29, 2008
Diagnostic accuracy of 2 oral fluid-based tests for HIV surveillance in NamibiaRaph L Hamers, Ingrid H de Beer, Harold Kaura, et al.
Pageof 15